<DOC>
	<DOCNO>NCT01036763</DOCNO>
	<brief_summary>Documentation successful therapy tiotropium ( Spiriva Respimat ; Spiriva ( tiotropium 18 mcg capsule ) ) COPD patient require long-acting bronchodilator : description important outcome parameter accord physician assessment determine success therapy . Such data yet available . Also collection physician assessment patient assessment efficacy tolerability Spiriva Respimat , Spiriva ( tiotropium 18 mcg capsule ) .</brief_summary>
	<brief_title>Assessment Chronic Obstructive Pulmonary Disease ( COPD ) Therapy From Physicians Perspective Using Tiotropium Example</brief_title>
	<detailed_description>Study Design : observational</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion COPD patient require longacting bronchodilator accord approve Summary Product Characteristics ( SPC ) guideline Exclusion criterion Patients recruit general specific contraindication list Patient information leaflet Summary Product Characteristics applies .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>